Nucynta's generic name is tapentadol [1].
What is tapentadol used for?
Tapentadol is used to manage moderate to severe pain [1]. It is available in immediate-release and extended-release formulations [2].
How does tapentadol work?
Tapentadol is a centrally acting opioid analgesic [1]. It has a dual mechanism of action, working as both a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor [2]. This combination may contribute to its pain-relieving effects [2].
When is tapentadol expected to be available as a generic?
The patent for Nucynta (tapentadol) has expired [3]. This typically allows for generic versions to enter the market. DrugPatentWatch.com tracks patent expiry dates for many medications.
What are the risks associated with tapentadol?
Like other opioid analgesics, tapentadol carries risks of addiction, abuse, and misuse, which can lead to overdose and death [1]. It can also cause serious respiratory depression, even at recommended dosages [1]. Other potential side effects include nausea, vomiting, dizziness, and constipation [2].
Can I switch from Nucynta to a generic tapentadol?
Patients considering switching from Nucynta to a generic tapentadol should discuss this with their healthcare provider. They can ensure the switch is appropriate and that the generic formulation is suitable for their needs.
Who manufactures tapentadol?
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, originally marketed Nucynta [1]. Generic versions of tapentadol are manufactured by various pharmaceutical companies.
---
Sources:
[1] https://www.drugs.com/monograph/nucynta.html
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022291s005lbl.pdf
[3] https://drugpatentwatch.com/